Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vilmorin & Cie is a global leader in the seed industry, specializing in the breeding, production, and sale of vegetable and field seeds. As a core subsidiary of the Limagrain Group, the company leverages advanced plant biotechnology, including molecular biology and genomics, to develop high-performance seed varieties for professional farmers and gardeners. Their portfolio covers a wide range of crops such as corn, wheat, tomatoes, and carrots, focusing on traits like pest resistance, climate resilience, and nutritional quality. Headquartered in France, Vilmorin operates a vast international R&D network to drive innovation in sustainable agriculture. The company was delisted from Euronext Paris in 2023 following a simplified tender offer by its parent company, Limagrain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vilmorin.